EWALT 2023

Eastern and Western Association
of Liver Tumors (EWALT)

unimainz

Eastern and Western Association
of Liver Tumors (EWALT)

unimainz

The 25th Meeting of the Eastern and Western Association for Liver Tumors
EWALT 2023 | 8 – 10 November 2023 | Rheingoldhalle Mainz, Germany

Sponsoring

PLATINUM Sponsor

GOLD Sponsor

SILVER Sponsor

We thank our partners for their support

Sponsor +

Exhibitors

  • biomindz Standortentwicklungsgesellschaft Mainz mbH
  • BK medical Medizinische Systeme GmbH
  • Corza Medical GmbH
  • ERBE Elektromedizin GmbH
  • HepaNET
  • Humedics GmbH
  • Incyte Biosciences Germany GmbH
  • Karl Storz SE & Co. KG
  • MeVis Medical Soultions AG
  • Olympus Deutschland GmbH
  • Roche Pharma AG
  • Söring GmbH Medizintechnik

Further Industry Partners

  • Biotest AG
  • Cella Medical Solutions
  • General Logistics Systems Germany GmbH & Co. OHG
  • Siemens Healthineers
  • Taiho Oncology Europe GmbH

Transparency

We wish to inform you about the financial assistance of the participating companies according to their membership in FSA e.V. (Association for Voluntary Self-Control of the Pharmaceutical Industry), AKG e.V. (Association for Medicinal Products and Cooperation in the Health Sector) or because the companies have approved the publication.

Regardless of the above-mentioned memberships, the conditions and scope of financial assistance of all companies as well as specialist publishers who support the event will be published, if this is stipulated by the professional codes of the respective regional medical associations.

Moreover, this complies with the recommendations of the Federal Medical Association (Bundesärztekammer) on continuing medical education, 4th revised edition, last updated: 24 April 2015, p.11 et seq., section 32 para. (3) of the (Model) Professional Code for Physicians in Germany ((Muster-)Berufsordnung für die in Deutschland tätigen Ärztinnen und Ärzte – MBO), section 8 para. (1) no. 3 of the (Model) Continuing Medical Education Code (Musterfortbildungsordnung – MFO).

 

Astellas Pharma GmbH 9.500 EUR, AstraZeneca GmbH 28.500 EUR, Chiesi GmbH 9.600 EUR, Corza Medical GmbH 2.000 EUR, Ethicon, Johnson & Johnson Medical GmbH 10.000 EUR, Medtronic GmbH 20.000 EUR, Humedics GmbH 4.900 EUR, Incyte Biosciences Germany GmbH 4.900 EUR, Roche Pharma AG 4.900 EUR, Roche Pharma AG 4.300 EUR, Sirtex Medical Europe GmbH 15.000 EUR.